|
Volumn 414, Issue 2-3, 2001, Pages 233-243
|
Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT1A receptor agonist, using a behavioural model in rats
|
Author keywords
Behavioural pharmacology; Buspirone; Drug development; NONMEM (non linear mixed effects modelling); Pharmacokinetic pharmacodynamic modelling; S 15535; S 32784
|
Indexed keywords
1 (1,4 BENZODIOXAN 5 YL) 4 (2 INDANYL)PIPERAZINE;
1 (BENZODIOXAN 5 YL) 4 (5 HYDROXYINDAN 2 YL)PIPERAZINE;
BUSPIRONE;
DRUG METABOLITE;
DUPHAR;
PIPERAZINE DERIVATIVE;
PLASMA PROTEIN;
S 32784;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ANXIETY;
ARTICLE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG POTENCY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MALE;
MODEL;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
TRANQUILIZING ACTIVITY;
VOCALIZATION;
ANIMALS;
ANTI-ANXIETY AGENTS;
BUSPIRONE;
MALE;
NONLINEAR DYNAMICS;
PIPERAZINES;
RATS;
RATS, WISTAR;
RECEPTORS, SEROTONIN;
RECEPTORS, SEROTONIN, 5-HT1;
SEROTONIN AGONISTS;
VOCALIZATION, ANIMAL;
|
EID: 0035793983
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(01)00801-9 Document Type: Article |
Times cited : (9)
|
References (30)
|